JM, Z., AD, S., A, M., WF, M., & S, P. (2019). Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: Results of a phase III clinical trial (FORWARD-3). Dove Medical Press.
Chicago Style (17th ed.) CitationJM, Zajecka, Stanford AD, Memisoglu A, Martin WF, and Pathak S. Buprenorphine/samidorphan Combination for the Adjunctive Treatment of Major Depressive Disorder: Results of a Phase III Clinical Trial (FORWARD-3). Dove Medical Press, 2019.
MLA (8th ed.) CitationJM, Zajecka, et al. Buprenorphine/samidorphan Combination for the Adjunctive Treatment of Major Depressive Disorder: Results of a Phase III Clinical Trial (FORWARD-3). Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.